Zinc-substituted hemoglobin with specific drug binding sites and fatty acid resistance ability for enhanced photodynamic therapy

Nano Research ◽  
2019 ◽  
Vol 12 (8) ◽  
pp. 1880-1887 ◽  
Author(s):  
Yiting Xu ◽  
Jiamei Xu ◽  
Xiaoxiao Hu ◽  
Xin Xia ◽  
Qian Dong ◽  
...  
1986 ◽  
Vol 34 (8) ◽  
pp. 3394-3402 ◽  
Author(s):  
KAZUO MARUYAMA ◽  
SHOJI AWAZU ◽  
HIDEO NISHIGORI ◽  
MOTOHARU IWATSURU

2017 ◽  
Vol 9 (1) ◽  
Author(s):  
Mónika Bálint ◽  
Norbert Jeszenői ◽  
István Horváth ◽  
David van der Spoel ◽  
Csaba Hetényi

1990 ◽  
Vol 269 (1) ◽  
pp. 217-221 ◽  
Author(s):  
K R Fox ◽  
E Kentebe

The interaction of echinomycin with a kinetoplast DNA fragment which contains phased runs of adenine residues has been examined by various footprinting techniques. DNAase I footprinting confirms that all drug-binding sites contain the dinucleotide CpG. However, not all such sequences are protected. Three sites, each of which is located between two adenine tracks in the sequence GCGA, are not protected from DNAase I attack. Enhanced cleavage by DNAase I, DNAase II and micrococcal nuclease is observed in regions surrounding drug-binding sites. The results suggest that echinomycin alters the conformation of the AT tracks, making them more like an average DNA structure. Echinomycin renders adenine residues in the sequence CGA hyper-reactive to diethyl pyrocarbonate.


Sign in / Sign up

Export Citation Format

Share Document